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I1030-50~N~u~~ll~MediatedHYP~~~n~i~nin~~~~ni~
FatigueSyndrome:DoeaLowSaltIntakePlaya
Role?
S.Girl, D. Waters, J. Kluger. Hav’ffordHospitaland the University of
Connecticut School of Medicine, Hsrtford, CT, USA
Because of recent reports linking neurally mediated hypotension, sodium
intake and chronic fatigue syndrome (CFS), we subjected 37 consecutive
patients with CFS, diagnosed according to CDCcriteria, tohead-uptilttesting
(HUT). HUT consiated of a 45 min tilt at 70Qfollowed by 15 reins with 1-2
@rein of an isoproterenol infusion. A positive response was defined as a
systolic blood prassures 70 mm Hg with syncope or pre-syncope.The mean
age of the pts was 30 * 13 years and 32 were women. Pts were interviewed
at baselina and after a follow-up of 21 + 14weeks. Details of symptoms, diet,
salt and water intake were obtained to test our hypothesis. After HUT,all pts
were started on a high salt diet (5-10 @day)with liberal water intake. Eight of
the HUT positive patients were also prescribed 0.1 mg/day of fludrocortisone
to augment high salt diet.
Ffesu/ts:HUT was positive in 27 pts (73%) and 31 (84%) had a low salt
intake for no medical reason. Reduced salt intake was predictive of HUT
positivity–25 of the 31 low salt pts (81%) being HUT positive veraus 2 of 6
pts (33%) on normal salt diets (p =0.016). Lightheadedness improved during
follow-up in 32 pts (87%), including 25 of 27 who had been HUT positive
versus 3 of 10 in HUT negative group (p= 0.074). CFS symptoms improved
in 19 pts (51%): 17 of 27 HUT positives versus.2 of 10 HUT negatives (p =
0.02). Also, a trend toward improvement in CFS symptoms was noted in pts
previously on a low salt diet (18/31 versus 1/6, p = 0.08).
Conclusions.’ 1) Neurally mediated hypotension frequently complicates
CFS and can be demonstrated with a two atage head-up tilt test. 2) A history
of a low aalt intake is associated with a positive head-up tilt test. 3) Patients
with CFS may benefit from a high salt intake. These observations should be
confirmed in a controlled trial.
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-[ MOm,iW~rende~fier~.u~.~Yo.a dia,,nfar.~ion
Betwaenthe ’80eandthe ’90ain Iarael
S. Gottlieb’, U. Goldbourt, D. Harpaz, V. Boyko, S. Stern, S. Behar, for the
SPRINT and the Israeli Thrombolytic Survey Group. Neufe/d Cardiac
Research Institute, TelHashomec Israel, 1r3ikurCholim Hospital,
JeN.SSh7t Isfed
The fate of patients with acute myocardial infarction (AMI) before and after
the advent of the reperfusion era remains of interest. Several studies have
reported a decline in mortality after AMI in the thrombolytic era. However, it ia
not clear whether the decline in mortality was parallel in men (M) and women
(W). We evaluated trends in mortality in two cohorts of AMI pts hospitalized
in the CCUSof Israel in 1961-83 (5639 pts; 4315 M, 74%) and in Jan-Feb of
1992 and 1994 (1940 pta; 1429 M, 74%).
f?esu/ts.’The clinical characteristics in both periods of M and W were
comparable. In both gendera administration of nitratas, 13-blockers,Ca. an-
tagonists, anti-plateleta, anti-coagulanta and ACE-inhibitora increased in the
‘90a. Thrombolysia, PTCWCABG and coronary angiography were not per-
formed in the ‘80s, and were done in 45%, 15% and 26Y0in M, respectively,
end insg~o, 11%and 20% in W, respectively, in the ‘90s. In-hospital compli-
cation of congestive heart failure and life threatening arrhythmias, were less
common in both gendera in the ‘90s. 30-day and I-yr age adjusted mortality
reteaand tha multivariate adjusted relative risk (RR) between the two periods
for M and W were (Table):
Mortality Men Women
‘s0s ’90s ‘s0s ’90s
(n =4S15) (n= 1429) ~!% Cl) (n= 1524) (n=511) &ACl)
30-day 17,0% 108% 0.66 24.O”A 15,1% 0.66
(0.53-0.S2)
30-dayto l-yr
(0.50-0.s7)
e.1% 6.7% 0,77 12.5% 45”/0 0.57
(0.60-1.00) (0.30-0.S2)
l-yrcumulative 24.6% 16.9% 0.73 33.6% 21.0% 0.67
(0.62-0.S5) (0.55-0.61)
Conckrsions.’1)During the last decade a significant decline in in-hospital
complicstiona and in early- and I-yr mortality was noted among AMI pts in
Israel; 2) The mortality declined in the order of 30%, similarly in both genders;
3) Changes in pta management contributed to the improved outcome.
[1031-591 VariatiOninLengthOfStayanciReadmiSaiOnfOr
PatientawithMyocardialInfarctionBetween1988
and1994
Z.-H. Liang, A.C. Wilson, J.B. Kostis, for the MIDAS. UMDNJ-Robt Wood
Johnson Medical Sch., New Brunswick, NJ, USA
Decreasing in-hospital mortality with shorter length of stay (LOS) has been
observed in patients with acute myocardial infarction (Ml). This study was
performed todescribethe recurrence of Ml and short-term mortality after hoa-
pital discharge, Using the database from New Jersey Myocsrdial Infarction
Data Acquisition System (MIDAS), we analyzed 11,764 patiants with primary
diagnosis of Ml who returned home at discharge in 1966 and 11,646 patients
in 1994. The median LOS was 8.2 days for patients discharged in 1966 and
7.6 days in 1994. Mortality rates 30 days after home discharge were 1.46Y0
for 1986 patients, and 1.32% for patients discharged in 1994 (NS). Read-
mission rates for Ml within 30 days of homa discharge were 1.&f~o for 1986
cohort and 2.28% for the 1994 cohort (p < 0.01). No significant association
between 30 day mortality and LOS was found in multivariate analyses with
adjustment for age, sex, race, cohort and a comorbidity index. Comparing
with patients who had LOS less than 5 days, patients with LOS 6-10 days
had RR 0.89 (95Y0Cl 0.75-1.30) and patients with LOS greater than 10 days
had RR 1.41 (95% Cl 0.89-1.91). However, patients who had a short hospital
stay were more likely to have recurrence of ML The adjusted RRs were 1.21
(1.00-1.91) for patients with LOS 6-10 daya and 1.41 (95% Cl 0.89-1.91)
for patients with LOS greater than 10 days. The data suggest that shorter
LOS is associated with a higher readmission rate. Further study is needed to
characterize tha patients with high risk of reinfarction after home discharge.
-1 MOrningCardia.E.entSin73,414Patienta:A
Meta-Analyaia
M.A. Mittleman, M.C. Cohen, J.E. Muller. /PCD, Cardiovascular Division,
Deaconess Hospital, Harvard Medical School, Boston, MA, USA
The incidence of myocardial infarction (MI) and sudden cardiac death (SCD)
peak in the morning. However,the fraction of all Mls and SCDathat contribute
to thia excess incidence has not been studied. We identified 19 studies of
Ml and 14 of SCD published since 19e5 and extracted the number of Mls
and SCDS occuring in each time period. Becauae studies presented data
in intervals ranging from 1- to 6-hours, we pooled events into four 6-hour
blocks.
A prioti we de@d the period of intereat to be from 0800-1159, and used
the remaining 18 hours of the day to estimate the expected number of events
in each 6-hour period. The figure shows the circadian pattern of Ml and SCD.
Of 55,633 Mls, 17,781 (32%) occurred between 0600-1159, compared to
12,617 expected. The risk of Ml was 42% higher in the morning compared
to the rest Ofthe day (95Y0 Cl: 39% tO4%), aCCOUntiflgfOr9.3~o Ofall Mls
(95% Cl: 9.0% to 9.5%). of 8,869 SCDS, 2,643 occurred between 0600-
1159, compared to 2,009 expected. The risk of SCD was 42% higher in the
morning compared to the rest of the day (95% Cl: 36Y0to 47%), acccmnting
for 9.4% of all SCDS(95% Cl: 8.8% to 10.0%).
n = Excessincidenceofmorninginfarctions
= Expectednumberof infarctions
Corrckrsion:Interventions that eliminate the morning peak of Ml and SCD
have the potential to prevent over 9% of Mls and SCDS.
] 1031-61 I Five-YearCeueeOfDeathAneiYaiSintheNHLBl
PTCARegietry:RaaulteandConeiderationafor
EvaluatingLong-TermSuwival
K.E. Kip’, D.R. Holmes, Jr.z, S.F. Kelsey, K.M. Detre 1.1 The Univemiiy of
Pittsburgh, Pittsburgh, PA, USA, 2 The Mayo Clinic, Rochestec MN, USA
Coronaty procedures are now commonplace in elderly patients (pts), and
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background mortality may be high in these pts, particularly when followed
long-term. Five-year (5 yr) cause of death, determined from autopsy and
death certificate information, was analyzed in 2123 coronary angioplasty pts
(mean age at baseline= 57.5) without acute Ml in the NHLBI PTCA Registry.
There were 200 deaths (9.4%) at 5 yr fu with 52.5% attributed to cardiac
causes. Pts with low ejeetion fraction, prior bypass surgery, inoperable/high
surgical risk, or multi-vessel disease had elevated 5 yr cardiac mortality.
Pts with history of diabetes, congestive heart failure or severe concomitant
disease had elevated rates of both cardiac and non-cardiac mortality. As
length of fu increased, a crossover from cardiac to non-cardiac mortality was
pronounced in older pts (table). In multivariate analysis, age>= 65 strongly
predieted 5 yrrie.kof non-cardiac mortality (RR =3.42, p c 0.001) but was not
predictive of cardiac mortality. Conclusions: Both all-cause and Cardiac-only
mortality should be evaluated in coronary intewention studies involving older
pts and long-term fu. Otherwise, conclusions related to treatment efficacy
and prognostic factors may be inappropriate. Similarly, non-fatal cardiac
outcomes (i.e. anginal atatus, repeat revascularization) seem particularly
important in corona~ Intervention studies involving older pts and long-term
fu.
Patienl age CumulativeCardiac (C)/Non-Cardiac (NC)
at baseline MortalityRats Ratio at Follow-upIntervals
6 men. 1 yr. 2 yr. 3 yr. 4 yr. 5 yr.
<65 vears 5.0 t ,s 2.0 1,7 1,6 1.5
>65 years 1.9 1.4 1,5 1.0 0,s 0.s
Cum. deaths C/NC 26/12 35122 5S/32 68/52 s7i74 lo5te5
11031-621 ~;~~g~:J;:AE.~~W.. S.~.y~fS..d.V.V
EUROASPIRE Study Group. Cardiac Medicine, National i-feartand Lung
/nstitute, /mperfa/ College School of Medicine, University of London, UK,
Depwment of Public Health, University of Gent, Belgium
A European survey in nine countries (Czech Republic, Finland, France, Ger-
many, Hungary, Italy, Netherlands, Slovenia and Spain) was undertaken to
measure the potential for secondary prevention of coronary heart disease.
Consecutive patients (S 70 years) from four diagnostic groups – CABG,
PTCA, AMI and acute myocardial ischaemia without infarction-were identi-
fiedfromthecentres and they were then invited forinterviewand examination
at least six montha after the acute procedure or event. 4663 medical records
were reviewed and 3569 (737.) patients atfended for interview. In all patients
combined the prevalence (range between centres) of risk faetor6at interview
was: 19% (13Y0Fin - 32Y0Ne) Currerdcigarette smokers; 25% (19% Net -
33% Fra) had a I.xxly mass index >30 kg/m2; 53% (48% Fra - 61% Cze)
had hypertension; 44% (36% Spa - 56% Ita) had a total cholesterol of ? 5.5
mmol/l; 18% (14% Ger - 27Y0Hun) were diabetic; and 5394 (33% Spa -
71% Fin) had a positive family histoty of CHD. Reported prophylactic drug
therapy was as follows: 87°A (72% Hun – 86% Ita) antiplatelets or anticoag-
ulants; 54% (35% Spa - 76% Fin) beta blockers; 307. (17% Fin - 46% Hun)
ACE inhibitors; 32% (22% Hun - 42% Fra) lipid lowering drugs; and 10%
(7% Fin - 16% Spa) anti-diabetic druge. There was considerable variation
in the prevalence of risk factors and drug use between centres and also
between diagnostic categories. In patients with coronary disease in Europe
there is still considerable medical potential to reduce the risk of a futiher
major ieehaemic event.
m1031 63 Air ForcefTexas Coronary AtheroscleroaiePrevention Study: Deeign and Baseline
Characteristics
E. Whitney, M. Clearfield, J.R. Downs, D.R. Shapiro, E.A. stein, p.A. Beerei
A.M. Gotto. Wilford Hall Medical Centec San Antonio, TX, USA, University
of North TexaaHealth Science Centac Fort Worth, TX, USA
Characteristic N (%) Lipid m~dl
Gsnder: M 5608 (65) Mean Total-C + S.D. 221 l 21
F 997 (15)
Race: White 5s60 (89) Mean HDL+ S.D, 37* 6
Hispanic 4s7 (7)
Black 206 (3) Mean LDL + S.D. 150 i 17
+ Family Hx CHD 1035 (16) Median TG (Range) 15S (35-620)
Active Smoker 816 (12) Ratio
Hypertension 1439 (22) LDUHDL 4.2 * 0.8
Diabetes 153 (2) Totel-C/HDL 6.1 + 1.1
Unique features of this trial are 1) the inclusion of unstable angina in the
primary endpoint, 2) treatment to a LDL goal lees than current NCEP guide-
lines and 3) a cohort that includes women, elderly and those with ‘normal’
cholesterol, mild-moderately elevated LDL and low HDL. The outcome may
help to clarify the role, in primary prevention, of aggressive LDL reduction to
delay or prevent acute coronary events in a relatively high risk population.
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11032-38I RegionalVariation ihRatea of Cardiac
Catheterization in Stable Angina Patients
Undergoing Myocardial Perfusion Imaging
L.J, Shaw, R. Hachamovitch, G.V. Heller, T.H. MarWick,K.L. Keeler,
M.S. Lauer, D.S. Berman, Ml. Travin, D,D. Miller, for the Emnomics of
Noninvasive Diagnoeis Study Group. Duke UniversiW Durham, NC, USA
Substantial variability in the rates of cardiac Catheterization (CATH) have
been reported. In a recent report from Northern New England, noninvasive
stress testing rates were highly correlated with rates of CATH. We compared
rates of CATH s 90 days in 7,706 stable angina patients referred for strees
perfusion imaging (41% reversible defect, CATH rate= 17%). A mt.dtivariable
risk-adjusted logistic regression analyeiewae performed. A clinical risk index
wae derived based upon a patient’s age, eex, eymptoms, and rick faefors
(35% female, mean age =65 years), CATH rates in 4 hoapitals were 29,22,
12, and 12%for Westcoast, Northeast (NE), Central NE, and Midwest. Ueing
Westcoast as a reference, CATH rates were 20-66% lower in other regions
after controlling for clinical and nuclear variables (see fable).
Region n Odda Ratios of Site vs. Westcoast p value
Westcoaat 2,168 -
Northeast 1,416 0.32 (0.26-0,4) 0.002
Central NE 466 0.S (0.67-0.95) <0,001
Midweat 3,656 0.66 (0.51-0.S6) 0.01
Clinical risk (5%), perfusion defect extent (86%), and hospital cite (9%)
contributed independent information in predicting CATH.
Conckraiorr:Considerable regional variability exists in the uee of esrdiac
catheterization instable angina patients that is unexplained by the underlying
clinical or test risk markers. Other factors (e.g. access, referral patterns)
influence catheterization in this population.
-[ cOmpariSOnAndva,idatiOnofRiSkAdjustment
Modele For Obaerved And Predicted Mortellty of
PTCA
M, Moscucci, J. Seivers, S.G. Ellis, G.T. O’Connor, D.J. Malenka,
The AirForc@TexaeCoronary Atherosclerosis PreventionStudY(AFCAWWd2ApSD.w.M.Muller, E.R. Bates, S.W. Wems, E. Klein, K.A. Eagle. University of
ie a randomized, double-blind placebo-controlled primary preverition trial de-
signed to test the hypothesis that, in addition to a cholesterol lowering diet,
treatment with lovastetin (LOV), toachievea LDLgoalofs llOmg/dl, reduces
the combined incidence of fatal coronary heatt disease (CHD), non-fatal Ml
and uneteble angina.
Over three years, two cites randomized 6605 men and women, with
a mean age of 58 (Range 45-73) to either LOV (20 mg/day) or placebo
(PBO). To reach goal, blinded titration of LOV (and matched PBO) up to 40
mg daily is allowed All participants will be followed until either 320 have
had a primary endpoint or 5 years, whichever occurs last. Independently
adjudicated endpoints will be used for an intention-to-treat analysis. The
baseline characteristics of this study cohort are described below:
Michigan, Ann Arboc Ml, USA
Several risk adjustment models for PTCA mortalily have been recently re-
ported, but external validation. on independent data sets and on high risk
patient populations ie lacking. Between 7/1/94 and 8/1/95, 1476 cxmaeeutive
proeeduree were performed on a high rick patient population characterized
bya high incidence of cardiogenic shock (3.3%) and acute myocardial infarc-
tion (14.3%). in hospital mortality was 3.4% (ehook 48.9%, acute Ml 12.&!’fo,
non Ml 1.4%). Multivariable analysie identified emergency procedure, age,
female gender, eardiogenic shock, pre-procedure administration of iv. NTG,
IABP requirement, LVEDP,and disease eeverity ae independent predietore
of in hospital mortality.Pre-proeedure ueeof aspirin was protective. The area
under the ROC cuwe for mortality wae 0.92, and the Lemeshow-Hosmer
